Regulatory changes are impacting the market listing status of companies on the New York Stock Exchange, involving the SEC.
1 report, 1 independent
Updated Jul 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Regulatory changes are impacting the market listing status of companies on the New York Stock Exchange, involving the SEC.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Saratoga Investment Corp received a BBB investment grade rating from Egan-Jones and is planning to list its notes on the NYSE.Sub-event
- Cosan intends to voluntarily delist its American Depositary Shares from the NYSE and file disclosures with the SEC.Sub-event
NYSE is commencing delisting proceedings for SOLAI Limited after applying to the SEC.1 source
Keep exploring
The entities involved
-
New York Stock Exchange
American stock exchange
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- Stock trades occurred on the NYSE platform while filing disclosures with the SEC.
- Teva Pharmaceutical Industries Ltd. is transitioning its stock from American Depositary Shares (ADS) to a direct listing on the NYSE.
- Douglas Emmett was listed on the New York Stock Exchange and is subject to SEC filings.
- Boston Scientific announced major restructuring via filings with the NYSE and SEC on July 28, 2026.
- Natuzzi failed to meet continued listing standards on the New York Stock Exchange and faces potential delisting.